MeiboClean+ HOCl
Clarity. Comfort. Relief.
The Advanced Daily Eyelid & Gland Cleanser
Presented to Eye Care Professionals | Malaysia
The Root Cause of Dry Eye Discomfort
Meibomian Gland Dysfunction (MGD) is the leading cause of Dry Eye Disease, affecting up to 86% of dry eye patients1.
Blocked glands fail to secrete the essential lipid layer of the tear film, leading to rapid tear evaporation, inflammation, and chronic discomfort.
Limitations of Current Regimens
Traditional methods for lid hygiene can be incomplete or irritating.
Warm Compresses & Massage
Help melt hardened meibum.
Limitation:
Does not remove scurf, debris, or biofilm from the lid margin. Patient compliance is often low.
Conventional Lid Scrubs
(e.g., Baby shampoo-based)
Limitation:
Can strip essential lipids, disrupt the tear film, and cause significant stinging and irritation.
A Dual-Action Approach to Lid Margin Health
Gently Lifts & Clears Debris
Cocamidopropyl Betaine, a gentle surfactant, effectively dissolves hardened meibum, makeup, and biofilm without stripping natural oils.
Purifies & Calms the Lid Margin2
Pure Hypochlorous Acid (HOCl), a natural part of the immune system, powerfully reduces bacterial load and calms inflammation.
Exceptionally Gentle & Non-Irritating
pH-balanced and preservative-free, ensuring comfort for even the most sensitive eyes.
Unblocking the Glands: A Two-Step Process
MeiboClean+ first dissolves the blockage, then purifies the area to restore function.
1. Blocked & Inflamed Gland
Hardened meibum, bacteria, and debris form a plug at the gland opening. This leads to inflammation of the eyelid margin and poor tear quality.
2. Gentle Surfactant Action
Cocamidopropyl Betaine molecules are applied. They gently emulsify and break down the lipid-based meibum plug, lifting it away from the gland opening.
3. HOCl Purification
Hypochlorous Acid (HOCl) then rapidly neutralizes bacteria on the lid margin and within the gland, reducing the source of inflammation and preventing recurrence.
Result: Clear Gland & Healthy Tear Film
The gland is now clear to secrete healthy, liquid meibum, which forms a stable lipid layer on the tear film, preventing evaporation and providing lasting comfort.
Clinically Meaningful Improvements
Proven to restore gland function and improve patient-reported outcomes.
Tear Film Stability
>2.5 second Increase
In average Tear Break-Up Time (TBUT) after 4 weeks of daily use.
Symptom Relief
>50% Reduction
In Ocular Surface Disease Index (OSDI) patient symptom scores3.
Reduced Bacterial Load
>99% Reduction
Of common lid margin bacteria (e.g. S. epidermidis) in-vitro2.
Supporting Clinical Data: Visualizing the Impact
Data from clinical studies demonstrating significant improvements in both signs and symptoms of MGD.
Tear Film Stability Improvement (TBUT)
Baseline
~5s
After 4 Weeks
+2.5s
A significant increase in Tear Break-Up Time indicates a healthier, more stable lipid layer.
Patient-Reported Comfort
A >50% reduction in OSDI scores shows patients feel a dramatic decrease in dryness, grittiness, and irritation3.
Lid Margin Purification
HOCl achieves a >99% reduction in harmful bacteria, removing a key trigger for blepharitis and inflammation2.
Transforming Patient Lives
58-Year-Old Office Worker with Chronic MGD & Blepharitis
Day 0
Day 28
Key Outcome:
Significant reduction in lid margin erythema and telangiectasia. Patient reported substantial decrease in morning crusting and gritty sensation, allowing for more comfortable screen use throughout the day.
The Foundation of a Healthy Ocular Surface
MeiboClean+ is a vital tool for comprehensive patient eye care.
Optimize Surgical Outcomes
A clean lid margin is crucial pre-operatively to reduce the risk of endophthalmitis and improve post-op comfort for cataract and refractive patients.
Improve Contact Lens Wear
Reduces lipid and protein deposits on lenses, decreasing dryness and extending comfortable wear time for patients.
Enhance Patient Compliance
The simple, comfortable, once-daily application makes it an easy addition to a patient's routine, ensuring long-term success.
Set a New Standard for Lid Hygiene.
Incorporate advanced, targeted cleansing into your practice.
Contact your medical representative for pricing and in-office support.
Supporting Clinical References
-
1. Lemp, M. A., et al. (2012).
Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort. Cornea, 31(5), 472-478.
-
2. Stroman, D. W., et al. (2017).
Reduction in bacterial load using hypochlorous acid hygiene solution on eyelids. Clinical Ophthalmology, 11, 707-714.
-
3. Ngo, W., et al. (2016).
The role of lid hygiene in comparison to a placebo in the management of MGD. Journal of Optometry, 9(2), 83-93.
